Southern Implants wins FDA nod for Provata dental implant

Southern Implants North America recently received FDA 510(k) clearance for its internal hex dental implant system, the Provata.

The Provata is commercially available in the U.S. It complements the company’s External Hex Implant with an internal hex connection. It is available in three forms, including standard, a unique Co-Axis with Subcrestal Angle Correction and ProMax ultra-wide implant designs to give clinicians the tools to address different clinical cases.

“Our goal introducing the Provata to the North American market helps unite both the external and internal hex treatment options, serving loyal external hex customers and those in favor it the internal hex proving clinicians multiple opportunities based on purpose or preference,” Lars Janson, president of Southern Implants North America, said.

Southern Implants North America suggests that clinicians can maintain flexibility, reduce costs and simplify inventory using Provata. The dental implant only requires two prosthetic connection diameters and one surgical kit for the internal and external hex systems. It also maintains features like SINA’s Synergy Surface.

“I have used Provata in more than 200 cases and believe having both internal hex for the simplicity and external hex for more complex cases with one surgical kit makes it the most flexible system in the world. Clinicians in North America will undoubtedly by thrilled to have this option in their armamentarium,” said Swedish clinician Dr. Pär-Olov Östman.